Prelude Capital Management’s Livongo Health, Inc. Common Stock LVGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-600
Closed -$45K 2596
2020
Q2
$45K Buy
+600
New +$31.4K ﹤0.01% 1189

Prelude Capital Management's LVGO Position: Q4 2020 in Review

Prelude Capital Management sold out of Livongo Health, Inc. Common Stock (LVGO) in Q4 2020, closing a stake of 32,120 shares — an estimated $4.5M sold.

Prelude Capital Management first reported a position in LVGO in Q3 2019 and held it in 3 quarters. The position peaked at $4.5M in Q3 2020. 0 funds tracked by Wall St. Rank hold LVGO as of Q4 2020.

  • Prelude Capital Management reported no remaining Livongo Health, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • Prelude Capital Management sold 32,120 Livongo Health, Inc. Common Stock shares in Q4 2020, an estimated $4.5M.
  • Prelude Capital Management first reported a position in Livongo Health, Inc. Common Stock in Q3 2019 and held it in 3 quarters.
  • Prelude Capital Management's Livongo Health, Inc. Common Stock position peaked at $4.5M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Livongo Health, Inc. Common Stock as of Q4 2020.

Based on Prelude Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.